To generate a more robust phenotype, transgenic models harboring mutations on the APP and/or PSEN and the MAPT gene have been developed, like the 3xTg-AD or the TauPS2APP (Grueninger et al., 2010; Oddo et al., 2003). Here, APP is linked to Alzheimer disease.